Your browser doesn't support javascript.
loading
Rapid progress towards elimination of lymphatic filariasis in endemic regions of Myanmar as a result of 16 years of anti-filarial activities (2001-2016).
Win, Kyawt Mon; Tripathy, Jaya Prasad; Maung, Thae Maung; Oo, Tin; Thi, Aung; Lon, Khin Nan; Lin, Zaw.
Afiliação
  • Win KM; Vector Borne Diseases Control Program, Ministry of Health and Sports, Naypyitaw, Myanmar.
  • Tripathy JP; 2International Union Against Tuberculosis and Lung Disease, The Union South-East Asia Regional Office, New Delhi, India.
  • Maung TM; 3Department of Medical Research, Ministry of Health and Sports, Yangon, Myanmar.
  • Oo T; 3Department of Medical Research, Ministry of Health and Sports, Yangon, Myanmar.
  • Thi A; Vector Borne Diseases Control Program, Ministry of Health and Sports, Naypyitaw, Myanmar.
  • Lon KN; 4Yangon Regional Public Health Department, Department of Public Health, Ministry of Health and Sports, Yangon, Myanmar.
  • Lin Z; Vector Borne Diseases Control Program, Ministry of Health and Sports, Naypyitaw, Myanmar.
Trop Med Health ; 46: 14, 2018.
Article em En | MEDLINE | ID: mdl-29720887
ABSTRACT

BACKGROUND:

As Myanmar progresses towards lymphatic filariasis (LF) elimination, it is important to know how well the anti-filarial activities have performed. The present study was conducted to study the implementation of the key anti-filarial activities and their impact on key indicators of LF transmission.

METHODS:

A secondary analysis of aggregate program data on the anti-filarial activities was conducted in four endemic state/regions of Myanmar receiving at least six mass drug administration (MDA) rounds during 2001-2016.

RESULTS:

MDA coverage has been expanded to cover all the endemic implementation units (IUs), i.e., 45 by 2015 and 6 IUs out of them have already stopped MDA. The reported coverage of MDA ranges from 87 to 100% whereas surveyed coverage ranges from 78 to 100% among the eligible population. The prevalence of microfilaria has significantly declined especially in Magway from 4.7 to 0.2% and Sagaing region from 7.9 to 1.3% during 2001-2016. Around 2.5% of estimated cases of hydrocele were reported to the program during 2009-2014.

CONCLUSION:

Myanmar has achieved significant success in interrupting LF transmission through several MDA rounds with high coverage. However, morbidity reporting and management, being in its initial phase requires an active surveillance system for identifying and managing people with LF-associated morbidities under the program.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Trop Med Health Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Mianmar

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Trop Med Health Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Mianmar